Physician profile
Marci Ostroff
NPI 1295731461
$2,154.34
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $489 · 2020: $209 · 2021: $333 · 2022: $557 · 2023: $383 · 2024: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $490.21 | 2019-2023 | |
| Exeltis, USA INC. | $233.92 | 2019-2024 | Slynd |
| Evofem Biosciences, INC. | $135.15 | 2021-2024 | Phexxi |
| Lupin INC. | $129.03 | 2019-2020 | |
| Organon LLC | $126.76 | 2021-2024 | Nexplanon |
| Mayne Pharma Commercial LLC | $102.52 | 2021-2024 | |
| Astellas Pharma US INC | $102.14 | 2023-2024 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $96.06 | 2019-2020 | |
| Daiichi Sankyo INC. | $93.15 | 2019-2022 | |
| Coopersurgical, INC. | $83.62 | 2019-2021 | |
| Scynexis, INC. | $77.28 | 2022 | |
| Amag Pharmaceuticals, INC. | $69.49 | 2019 | |
| Myovant Sciences INC. | $62.26 | 2021-2022 | |
| Avion Pharmaceuticals | $53.28 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $51.24 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $33.60 | 2019 | |
| Merck Sharp & Dohme LLC | $32.41 | 2019-2020 | |
| Biogen, INC. | $25.78 | 2024 | |
| Hologic Sales and Service, LLC | $24.50 | 2023 | Aptima |
| Ethicon US, LLC | $21.55 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.70 | 2023 | |
| Allergan, INC. | $20.58 | 2019 | |
| Pfizer INC. | $20.53 | 2024 | |
| Optumhealth Care Solutions, LLC | $18.79 | 2023 | Vivify Health Care Team Portal |
| Sumitomo Pharma America, INC. | $16.61 | 2023 | Myfembree |
| Mission Pharmacal Company | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marci Ostroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.